Kowal Investment Group’s Sanofi SNY Stock Holding History

Kowal Investment Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-95	Closed	-$5K	–	808
2021 Q3	$5K	Buy	+95	New	+$4.83K	﹤0.01%	665

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Kowal Investment Group's SNY Position: Q4 2021 in Review

Kowal Investment Group sold out of Sanofi (SNY) in Q4 2021, closing a stake of 95 shares — an estimated $5K sold.

Kowal Investment Group first reported a position in SNY in Q3 2021 and held it in 1 quarter. The position peaked at $5K in Q3 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

Kowal Investment Group reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 95 Sanofi shares in Q4 2021, an estimated $5K.
Kowal Investment Group first reported a position in Sanofi in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Sanofi position peaked at $5K in Q3 2021.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.